AngioDynamics, Inc. (NASDAQ: ANGO) Surpasses Q1 Fiscal 2026 Earnings Expectations

AngioDynamics, Inc. (NASDAQ:ANGO) reported a narrower-than-expected Q1 fiscal 2026 loss per share of $0.10, beating the Zacks Consensus Estimate.The company's revenue reached $75.71 million, marking a 12.2% year-over-year increase, driven by significant growth in its Med Tech segment.AngioDynamics raised its fiscal year 2026 sales outlook to $308 million to $313 million, reflecting confidence in continued growth.AngioDynamics, Inc. (NASDAQ:ANGO), a prominent figure in the medical technology industry, focuse ...